Pathophysiology of CML: Do defects in integrin function contribute to the premature circulation and massive expansion of the BCR/ABL positive clone?

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 6, 1997, Pages 584-591

  Verfaillie, Catherine M ^a   Hurley, Randolph ^a   Zhao, Robert C H ^a   Prosper, Felipe ^a   Delforge, Michel ^a   Bhatia, Ravi ^a  

^a Box 480 ^*

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031171762     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90192-X     Document Type: Conference Paper

References (52)

1. Verfaillie CM, Hurley R, Bhatia R, McCarthy JB. Role of bone marrow matrix in normal and abnormal hematopoiesis. Crit Rev Oncol/Hematol 1994;16:201-4.
2. Williams DA, Rios M, Stephens C, Patel VP. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 1991;352:438-41.
3. Papayannopoulou T, Craddock C, Nakamoto B, Priestley GV, Wolf SN. The VLA4/VCAM adhesion pathway defines contrasting mechanisms of lodging of transplanted murine hematopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA 1995;92:9647-51.
4. 4 remain "homeless" and persist in circulation [abstract]. Blood 1994;84(suppl 1)1962.
5. Papayannopoulou T, Nakamato B. Systemic treatment of primates with anti-VLA4 leads to an immediate egress of hemopoietic progenitors to periphery. Proc Natl Acad Sci USA 1993;90:9374-8.
6. Hirsch E, Iglesias A, Potocnik AJ, Hartmann U, Fässler R. Impaired migration but not differentiation of haematopoietic stem cells in the absence of β1 integrins. Nature 1996;380:171-5.
7. Bruno E, Luikart SD, Long MW, Hoffman R. Marrowderived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines. Exp Hematol 1995;23:1212-7.
8. Long MW, Dixit VM. Thrombospondin functions as a cytoadhesion molecule for human hematopoietic progenitor cells. Blood 1990;75:2311-8.
9. Verfaillie CM, McCarthy JB, McGlave PB. Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin. J Exp Med 1991;174:693-703.
10. Simmons PJ, Masinovsky B, Longenecker BM, Berenson R, Torok-Storb B, Gallatin WM. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 1992;80: 388-95.
11. Verfaillie CM, Benis A, Iida G, McGlave PB, McCarthy J. Adhesion of committed human hematopoietic progenitors to synthetic peptides in the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin α4β1 and the CD44 adhesion receptor. Blood 1994;84: 1802-12.
12. hi stem cells to bone marrow stroma. J Clin Invest 1992;90:358-67.
13. Dercksen MW, Gerritsen WR, Rodenhuis S, et al. Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation. Blood 1995;85: 3313-22.
14. Verfaillie CM. Direct contact between progenitors and stroma is not required for human in vitro hematopoiesis. Blood 1992;79:2821-6.
15. Hurley RW, McCarthy JB, Verfaillie CM. Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 1995; 96:511-9.
16. Hurley R, McCarthy JB, Verfaillie CM. Clustering of integrins results in proliferation inhibition of committed hema-topoietic progenitors through mechanisms involving the cell cytoskeleton. Exp Hematol (in press).
17. Schwartz MA, Schaller MD, Ginsberg MH. Biology of Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev 1995;11:549-99.
18. Zigmond SH. Signal transduction and actin filament organization. Curr Opin Cell Biol 1996;8:66-73.
19. Craig SW, Johnson RP. Assembly of focal adhesions: progress, paradigms, and portents. Curr Opin Cell Biol 1996; 8:74-85.
20. Schaller MD, Parsons JT. Focal adhesion kinase and associated proteins. Curr Opin Cell Biol 1994;6:705-10.
21. Schlaepfer DD, Hanks SK, Hunter T, van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994;372: 786-9.
22. Yurochko AD, Liu DY, Eierman D, Haskill S. Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. Proc Natl Acad Sci USA 1992;89:9034-8.
23. Zhu X, Ohtsubo M, Böhmer RM, Roberts JM, Assosian RK. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J Cell Biol 1996; 133:391-403.
24. Guadagno TM, Ohtsubo M, Roberts JM, Assosian RK. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 1993;262:1572-5.
25. Fialkow PJ, Jacobson RJ, Papayannopoulou TH. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 1977;63:125-31.
26. Rowley JD. The Philadelphia chromosome translocation: a paradigm for understanding leukemia. Cancer 1990;65:2178-82.
27. Bartram CR, deKlein A, Hagemeijer A, et al. Translocation of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukemia. Nature 1983; 306:277-80.
28. Bathia R, Dewald G, McGlave P, Verfaillie CM. Abnormalities of the bone marrow microenvironment in chronic myelogenous leukemia are related to maliganant macrophages. Blood 1995;85:3636-45.
29. Bhatia R, Wayner E, McGlave P, Verfaillie CM. Interferon-α restores adhesion of malignant progenitors in CML by restoring β1 integrin function. J Clin Invest 1994;94:384-91.
30. Gordon MY, Dowdling CR, Riley GP, Goldman JM, Greaves MF. Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myeloid leukaemia. Nature 1984;328:342-4.
31. Verfaillie CM, JB McCarthy, PB McGlave. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin Invest 1992;90:1232-41.
32. Bedi A, Griffin CA, Barber JP, Vala MS, Hawkins AL, Sharkis SJ, et al. Growth factor mediated terminal differentiation of chronic myeloid leukemia. Cancer Res 1994;54: 5535-8.
33. Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 1994;83:2048-58.
34. McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR, Cotter TG. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 1994;83:1179-86.
35. Strife A, Clarkson B. Biology of chronic myelogenous leukemia: is discordant maturation the primary defect? Semin Hematol 1988;25:1-19.
36. Eaves AC, Cashman JD, Gaboury LA, Kalousek DK, Eaves CJ. Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci USA 1986;83:5306-10.
37. Bhatia R, McCarthy JB, Verfaillie CM. Interferon-α restores normal β1-integrin mediated negative regulation of chronic myelogenous leukemia progenitor proliferation. Blood 1996; 87:3883-91.
38. Bhatia R, Munthe H, Verfaillie CM. Decreased β1-integrin receptor capping in CML progenitors reflecting abnormal receptor-cytoskeletal interactions is normalized by inteferon-α [abstract]. Blood 1996;88(suppl 1):2537.
39. Bhatia R, Verfaillie CM. Inhibition of BCR/ABL expression by anti-sense oligonucleotides normalizes β1-integrin mediated adhesion and regulation of proliferation in chronic myelogenous leukemia [abstract]. Blood 1995;86(suppl 1)1740.
40. Bhatia R, Verfaillie CM. Inhibition of BCR/ABL tyrosine kinase activity by tyrphostin AG957 restores β1-integrin mediated microenvironmental regulation of hematopoietic progenitor proliferation [abstract]. Blood 1996;88(suppl 1):2668.
41. Kovach NL, Carlos TM, Yee E, Harlan JM. A monoclonal antibody to β1 integrin [CD29] stimulates VLA-dependent adherence of leukocytes to human umbilical vein endothelial cells and matrix components. J Cell Biol 1992;116:499-509.
42. Lundell BI, McCarthy JB, Kovach NL, Verfaillie CM. Adhesion to fibronectin (FN) induced by the activating anti-integrin-β1 antibody, 8a2, restores adhesion mediated inhibition of CML progenitor proliferation. Blood 1996; 87:2450-8.
43. bcr/abl gene of the Philadelphia chromosome. Science 1990;247:824-9.
44. Gishizky ML, Witte ON. Initiation of dysregulated growth of multipotent progenitor cells by bcr-abl in vitro. Science 1992; 256:836-9.
45. Pendergast AM, LA Quilliam, LD Cripe, et al. BCR-ABL-Induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993; 75:175-85.
46. Oda T, Heaney C, Hagopian JR, Okuda K, Griffin JD, Druker BJ. Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia. J Biol Chem 1994;269:22925-8.
47. BCR/ABL to the phosphatidylinositol-3' kinase pathway. Oncogene 1996;12:839-46.
48. Zhang Z, Vuori K, Wang H-G, Reed JC, Ruoslahti E. Integrin activation by R-ras. Cell 1996;85:61-9.
49. Gotoh A, Miyazawa K, Ohyashiki K, Tauchi T, Boswell HS, Broxmeyer HE, et al. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. Exp Hematol 1995;23:1153-62.
50. Salgia R, Li JL, Lo SH, et al. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL. J Biol Chem 1995;270:5039-47.
51. Skorski T, Kanakaraj P, Nieborowska-Skorska M, et al. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood 1995;86:726-36.
52. McWhirter JR, Wang JY. An actin-binding function contributes to transformation by the bcr/abl oncoprotein in Philadelphia chromosome positive human leukemias. EMBO J 1993;12:1533-46.